FY2026 Earnings Estimate for Cardinal Health, Inc. (NYSE:CAH) Issued By Leerink Partnrs

Cardinal Health, Inc. (NYSE:CAH - Free Report) - Investment analysts at Leerink Partnrs lowered their FY2026 EPS estimates for Cardinal Health in a research note issued on Monday, April 22nd. Leerink Partnrs analyst M. Cherny now expects that the company will post earnings of $8.48 per share for the year, down from their previous forecast of $9.19. Leerink Partnrs currently has a "Outperform" rating on the stock. The consensus estimate for Cardinal Health's current full-year earnings is $7.28 per share. Leerink Partnrs also issued estimates for Cardinal Health's FY2027 earnings at $9.38 EPS and FY2028 earnings at $10.50 EPS.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Thursday, February 1st. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.56 by $0.26. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The firm had revenue of $57.45 billion during the quarter, compared to analysts' expectations of $57.02 billion. During the same period in the previous year, the company earned $1.32 earnings per share. The firm's quarterly revenue was up 11.6% on a year-over-year basis.

Several other analysts have also issued reports on CAH. Argus upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating in a research report on Friday, February 9th. SVB Leerink assumed coverage on shares of Cardinal Health in a research report on Monday, February 26th. They set an "outperform" rating and a $125.00 target price for the company. Barclays assumed coverage on shares of Cardinal Health in a research report on Wednesday, January 3rd. They set an "overweight" rating and a $117.00 target price for the company. UBS Group boosted their target price on shares of Cardinal Health from $122.00 to $125.00 and gave the company a "buy" rating in a research report on Monday, February 5th. Finally, TheStreet lowered shares of Cardinal Health from a "b-" rating to a "c+" rating in a research report on Wednesday, December 27th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Cardinal Health presently has an average rating of "Moderate Buy" and a consensus price target of $103.07.

Cardinal Health Stock Performance

Shares of CAH traded up $0.16 during mid-day trading on Wednesday, hitting $103.54. 2,057,471 shares of the company traded hands, compared to its average volume of 2,274,126. The stock has a 50-day moving average price of $109.56 and a two-hundred day moving average price of $104.59. Cardinal Health has a 1 year low of $77.56 and a 1 year high of $116.04. The stock has a market cap of $25.18 billion, a price-to-earnings ratio of 40.76, a P/E/G ratio of 0.99 and a beta of 0.68.

Institutional Investors Weigh In On Cardinal Health

A number of institutional investors have recently added to or reduced their stakes in the stock. Ameriprise Financial Inc. grew its holdings in Cardinal Health by 82.2% during the 3rd quarter. Ameriprise Financial Inc. now owns 4,128,009 shares of the company's stock valued at $358,390,000 after buying an additional 1,862,291 shares in the last quarter. Northern Trust Corp boosted its position in shares of Cardinal Health by 0.9% during the 3rd quarter. Northern Trust Corp now owns 3,340,547 shares of the company's stock valued at $290,026,000 after acquiring an additional 28,412 shares during the last quarter. Pacer Advisors Inc. boosted its position in shares of Cardinal Health by 17.5% during the 4th quarter. Pacer Advisors Inc. now owns 2,619,561 shares of the company's stock valued at $264,052,000 after acquiring an additional 389,431 shares during the last quarter. Norges Bank bought a new position in shares of Cardinal Health during the 4th quarter valued at approximately $258,499,000. Finally, AQR Capital Management LLC boosted its position in shares of Cardinal Health by 0.8% during the 3rd quarter. AQR Capital Management LLC now owns 2,496,531 shares of the company's stock valued at $216,749,000 after acquiring an additional 19,287 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were issued a dividend of $0.5006 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.93%. The ex-dividend date was Thursday, March 28th. Cardinal Health's dividend payout ratio (DPR) is currently 78.74%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.